GLP Watchdog

GoodRx vs Mochi Health

Neither GoodRx nor Mochi Health has an FDA warning letter on record. On Foundayo (orforglipron) pill, Mochi Health costs $468 less a year at standing rates: $110 a month against $149 a month at GoodRx.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

GoodRx / Mochi Health

GoodRx logo

GoodRx

7.8/10

Mochi Health logo

Mochi Health

7.1/10

FDA warning letters
None on record
None on record
Pharmacy
Brand-name only; no compounding
None named in our record
Lowest standing price
$149/moFoundayo (orforglipron) pill
$110/moFoundayo (orforglipron) pill
States
48 states
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit GoodRx
Visit Mochi Health

Neither GoodRx nor Mochi Health pays us. Links to them earn nothing. Scores: GoodRx 7.8, Mochi Health 7.1. How we are paid

What the record shows

  1. 01

    Neither GoodRx nor Mochi Health has an FDA warning letter on record.

  2. 02

    Mochi Health names no compounding pharmacy in our record. GoodRx sells brand-name medication only.

  3. 03

    On Foundayo (orforglipron) pill, Mochi Health costs $468 less a year at standing rates: $110 a month against $149 a month at GoodRx.

  4. 04

    Only Mochi Health lists a price for compounded semaglutide injection, compounded tirzepatide injection and brand-name semaglutide pen.

  5. 05

    Mochi Health covers two states GoodRx does not.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

GoodRx

Mochi Health

Brand-name tirzepatide pen

$299/mo

$3,588 a year

$299/mo

medication only, membership extra; not compared

Foundayo (orforglipron) pill

$149/mo

$1,788 a year

$110/moLower

$1,320 a year

Compounded semaglutide injection
Not sold or not priced

$139/mo

plan terms unclear; not compared

Compounded tirzepatide injection
Not sold or not priced

$169/mo

plan terms unclear; not compared

Brand-name semaglutide pen
Not sold or not priced

$199/mo

medication only, membership extra; not compared

Compounded oral semaglutide
Not sold or not priced

$141/mo

$1,692 a year

Brand-name semaglutide pill
Not sold or not priced

$149/mo

medication only, membership extra; not compared

Price includes
Not stated
Clinician visits, coaching
Billed separately
Not stated
Medication
Cancel any time
Yes, stated
Yes, stated
Minimum term
None
None on the monthly plan; 3, 6 and 12-month memberships are prepaid
Refunds
Services and medication are generally non-refundable
No refunds for partly used periods; medication is not refundable once sent to the pharmacy

Read off each seller’s own pages. GoodRx: October 30, 2026. Mochi Health: October 31, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for GoodRx

7.8/10

The record gives GoodRx no edge on this pair.

Visit GoodRx

The case for Mochi Health

7.1/10
  • $468 a year less on Foundayo (orforglipron) pill
  • Sells compounded semaglutide injection and compounded tirzepatide injection, which GoodRx does not price
  • Names no compounding pharmacy
  • Price leaves out medication
Visit Mochi Health

Scores

GoodRx 7.8 · Mochi Health 7.1 out of 10. Six weighted parts.

Value25%

8.7A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

5.0A
vs
B
7.5

Trust & Safety15%

6.0A
vs
B
8.5

Accessibility10%

9.7A
vs
B
10.0

Support10%

5.0A
vs
B
4.0

The score is the same formula for every seller. Payment does not enter it. Method

GoodRx vs Mochi Health: questions

Neither GoodRx nor Mochi Health has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Mochi Health names no compounding pharmacy in our record. GoodRx sells brand-name medication only.
Mochi Health, by $468 a year at standing rates. GoodRx: $149 a month, about $1,788 a year. Mochi Health: $110 a month, about $1,320 a year.
GoodRx states you can cancel at any time; refunds: services and medication are generally non-refundable. Mochi Health states you can cancel at any time; refunds: no refunds for partly used periods; medication is not refundable once sent to the pharmacy.
Neither GoodRx nor Mochi Health pays us. Links to them earn nothing. Scores: GoodRx 7.8, Mochi Health 7.1.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks